Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of FBXO17 gene expression in high-grade glioma.

BMC cancer - 31 Jul 2018

Du Di, Yuan Jian, Ma Wencai, Ning Jing, Weinstein John N, Yuan Xianrui, Fuller Greg N, Liu Yuexin

Abstract excerpt

BACKGROUND: High-grade gliomas (HGGs) exhibit marked heterogeneity in clinical behavior. The purpose of this study was to identify a novel biomarker that predicts patient outcome, which is helpful in HGG patient management. METHODS: We analyzed gene expression profiles of 833 HGG cases, representing the largest patient population ever reported. Using the data set from the Cancer Genome Atlas (TCGA) and random...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Brain Neoplasms
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Epigenesis, Genetic

Share to F-Box Proteins

Share to Glioma

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 30064493
DOI: 10.1186/s12885-018-4680-3
PMCID: PMC6069786

Genes

FBXO17
IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of FBXO17 gene expression in high-grade glioma.PMID 30064493Read ↗

A gene signature predicting prognosis of patients with low- grade gliomas receiving temozolomide therapySemantic proximity Read ↗

Identification of potential biomarkers related to glioma survival by gene expression profile analysisSemantic proximity Read ↗

Prognostic value and drug sensitivity of FBXL6 in gliomaSemantic proximity Read ↗

Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than HistologySemantic proximity Read ↗

Identification of an epigenetic prognostic signature for patients with lower‐grade gliomasSemantic proximity Read ↗

FXYD2 mRNA Expression Represents a New Independent Factor That Affects Survival of Glioma Patients and Predicts Chemosensitivity of Patients to TemozolomideSemantic proximity Read ↗

Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.Semantic proximity Read ↗

FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide.Semantic proximity Read ↗

Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative GroupSemantic proximity Read ↗

A 4-Gene Signature Associated with Clinical Outcome in High-Grade GliomasSemantic proximity Read ↗

Expression and prognostic role of E2F transcription factors in high‐grade gliomaSemantic proximity Read ↗

DNA methylation in glioblastoma: impact on gene expression and clinical outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.